Paclitaxel-coated balloon reduces target lesion revascularization compared with standard balloon angioplasty Nicholas Candy, MBBS, Eugene Ng, MBBS, Ramesh.

Slides:

Advertisements

Similar presentations

From: Sustained Safety and Effectiveness of Paclitaxel-Eluting Stents for Femoropopliteal Lesions: 2-Year Follow-Up From the Zilver PTX Randomized and Single-Arm.

Advertisements

Predictors of restenosis in the use of helical interwoven nitinol stents to treat femoropopliteal occlusive disease Yiu Che Chan, MBBS, MD, FRCS, Stephen.

Thomas F. O’Donnell, MD, Joseph Lau, MD Journal of Vascular Surgery

Predictors of restenosis in the use of helical interwoven nitinol stents to treat femoropopliteal occlusive disease Yiu Che Chan, MBBS, MD, FRCS, Stephen.

Systematic review and meta-analysis of randomized controlled trials evaluating long- term outcomes of endovenous management of lower extremity varicose.

Abd Moain Abu Dabrh, MBBCh, MS, Mark W

Percutaneous coronary invervention versus coronary artery bypass grafting: A meta- analysis Yolba Smit, MD, MSc, Joan Vlayen, MD, Hetty Koppenaal, MD,

AcoArt I Trial design: Patients with femoropopliteal artery disease were randomized to paclitaxel-coated balloon angioplasty (n = 100) vs. standard peripheral.

Courtney J. Warner, MD, MS, Spencer W. Greaves, MPH, Robin J

Regarding “A systematic review and meta-analysis of glycemic control for the prevention of diabetic foot syndrome” Michaela Beatrice Rehman, MD Journal.

Predictors of restenosis in the use of helical interwoven nitinol stents to treat femoropopliteal occlusive disease Yiu Che Chan, MBBS, MD, FRCS, Stephen.

Effect of beta-blockers on perioperative outcomes in vascular and endovascular surgery: a systematic review and meta-analysis S Hajibandeh, S Hajibandeh,

A systematic review and meta-analysis of the association between markers of hemostasis and abdominal aortic aneurysm presence and size David A. Sidloff,

Systematic review and meta-analysis of surgical interventions versus conservative therapy for venous ulcers Karen F. Mauck, MD, MS, Noor Asi, MD, Chaitanya.

Balloon angioplasty versus Viabahn stent graft for treatment of failing or thrombosed prosthetic hemodialysis grafts Thomas Vesely, MD, William DaVanzo,

Primary stenting of femoropopliteal atherosclerotic lesions using new helical interwoven nitinol stents Yiu Che Chan, MBBS, BSc, MD, FRCS, Stephen W.

Bayesian network meta-analysis of nitinol stents, covered stents, drug-eluting stents, and drug-coated balloons in the femoropopliteal artery Konstantinos.

Rupture rates of untreated large abdominal aortic aneurysms in patients unfit for elective repair Fran Parkinson, MB BCh, Stuart Ferguson, MB BChir,

Mohammad Hassan Murad, MD, MPH, Anas Shahrour, Nilay D

ILLUMENATE Trial design: Patients with superficial femoral artery (SFA) and/or popliteal arterial stenoses were randomized in a 2:1 fashion to either balloon.

A comparison of covered vs bare expandable stents for the treatment of aortoiliac occlusive disease Bibombe P. Mwipatayi, MMed (Surg), FCS (SA), FRACS,

Drug-Coated Balloon Angioplasty Confers No Advantage in the Treatment of Femoropopliteal Disease When Stenting Is Required Brian Tiu, MD, Michael Shih,

Balloon angioplasty compared with stenting for treatment of femoropopliteal occlusive disease: A meta-analysis Bibombe Patrice Mwipatayi, MMed (Surg),

The association between diabetes and thoracic aortic aneurysms

Systematic review or meta-analysis

Thomas F. O’Donnell, MD, Joseph Lau, MD Journal of Vascular Surgery

A randomized phase II study of Xilonix, a targeted therapy against interleukin 1α, for the prevention of superficial femoral artery restenosis after percutaneous.

Coronary artery bypass grafting is superior to first-generation drug-eluting stents for unprotected left main coronary artery disease: An updated meta-analysis.

Balloon angioplasty versus Viabahn stent graft for treatment of failing or thrombosed prosthetic hemodialysis grafts Thomas Vesely, MD, William DaVanzo,

A systematic review and meta-analysis of adjunctive therapies in diabetic foot ulcers Tarig Elraiyah, MBBS, Apostolos Tsapas, MD, PhD, Gabriela Prutsky,

Beating-Heart Versus Conventional On-Pump Coronary Artery Bypass Grafting: A Meta- Analysis of Clinical Outcomes Umar A.R. Chaudhry, MBBS, Leanne Harling,

Rohini Rao, BSc, Tristan R. A. Lane, MRCS, Ian J

Joel Cooper, MD, Adam H. Power, MPhil, MD, Guy DeRose, MD, Thomas L

Health-related quality-of-life outcomes after open versus endovascular abdominal aortic aneurysm repair Ahmed Kayssi, MD, MSc, MPH, Ann DeBord Smith,

A meta-analysis of anticoagulation for calf deep venous thrombosis

Results of the randomized, placebo-controlled clopidogrel and acetylsalicylic acid in bypass surgery for peripheral arterial disease (CASPAR) trial Jill.

A network meta-analysis of randomized controlled trials comparing treatment modalities for de novo superficial femoral artery occlusive lesions Constantine.

Todd R. Vogel, MD, MPH, Viktor Y. Dombrovskiy, MD, PhD, MPH, Paul B

Suprarenal versus infrarenal stent graft fixation on renal complications after endovascular aneurysm repair Larry E. Miller, PhD, Mahmood K. Razavi,

Meta-analysis of the effects of statins on perioperative outcomes in vascular and endovascular surgery George A. Antoniou, MD, PhD, MSc, FEBVS, Shahin.

Low-molecular-weight heparin for prevention of restenosis after femoropopliteal percutaneous transluminal angioplasty: A randomized controlled trial

Long-term results of a multicenter randomized study on direct versus crossover bypass for unilateral iliac artery occlusive disease Jean-Baptiste Ricco,

Impact of diabetes on carotid artery revascularization

Open versus endovascular treatment of subclavian artery atherosclerotic disease George C. Galyfos, MD, PhD, Ioannis Kakisis, MD, PhD, Chrisostomos Maltezos,

Percutaneous transluminal angioplasty versus primary stenting in infrapopliteal arterial disease: A meta-analysis of randomized trials Ridong Wu, MD,

A meta-analysis of dialysis access outcome in elderly patients

Hidde Jongsma, MD, Joost A. Bekken, MD, George P

Infrainguinal angioplasty with drug-eluting stents and balloons

Biniam Kidane, MD, MSc, Madelaine Plourde, MD, MSc, Sami A

Hisato Takagi, MD, PhD, Takuya Umemoto, MD, PhD

Angiographic outcomes of radial artery versus saphenous vein in coronary artery bypass graft surgery: A meta-analysis of randomized controlled trials

Open versus endovascular revascularization for chronic mesenteric ischemia: Risk- stratified outcomes Gustavo S. Oderich, MD, Thomas C. Bower, MD, Timothy.

Drug-eluting balloon angioplasty versus uncoated balloon angioplasty in patients with femoropopliteal arterial occlusive disease Hidde Jongsma, MD, Joost.

Comparison of Conservative Treatment and Thymectomy on Myasthenia Gravis Outcome Emanuela Taioli, MD, PhD, Philip Kent Paschal, Bian Liu, PhD, Andrew.

Do the EXCEL and NOBLE Trial Results Change Meta-Analysis Findings?

Yin-Shu Chang, MD, Jia-Xiang Wang, MD, PhD, Da-Wei Chang, PhD

Masatsugu Hamaji, MD, Syed Osman Ali, MD, Bryan M. Burt, MD

In-hospital and 30-day outcomes after tibioperoneal interventions in the US Medicare population with critical limb ischemia Todd R. Vogel, MD, MPH, Viktor.

Abd Moain Abu Dabrh, MBBCh, MS, Mark W

Endovascular treatment of atherosclerotic popliteal artery disease based on dynamic angiography findings Chaoyi Cui, MD, PhD, Xintian Huang, MD, Xiaobing.

Coronary Artery Bypass Revascularization Using Bilateral Internal Thoracic Arteries in Diabetic Patients: A Systematic Review and Meta-Analysis Kan Kajimoto,

The evidence-based surgical anatomy of the popliteal artery and the variations in its branching patterns Krzysztof A. Tomaszewski, MD, PhD, Patrick Popieluszko,

A comparison of percutaneous transluminal angioplasty versus amputation for critical limb ischemia in patients unsuitable for open surgery Spence M.

Outcome of drug-eluting balloon angioplasty versus endarterectomy in common femoral artery occlusive disease Tzu-Ting Kuo, MD, Po-Lin Chen, MD, Chun-Yang.

Ten-year experience with renal artery in-stent stenosis

Jon S. Matsumura, MD, Adnan Z. Rizvi, MD Journal of Vascular Surgery

The outcome of the proximal radial artery arteriovenous fistula

Results of a randomized clinical trial of external beam radiation to prevent restenosis after superficial femoral artery stenting Eric Therasse, MD,

M. Hassan Murad, MD, MPH, David N. Flynn, BS, Mohamed B

Hisato Takagi, MD, PhD, Masafumi Matsui, MD, Takuya Umemoto, MD, PhD

Presentation transcript:

Paclitaxel-coated balloon reduces target lesion revascularization compared with standard balloon angioplasty Nicholas Candy, MBBS, Eugene Ng, MBBS, Ramesh Velu, MS, FRCS, FRACS Journal of Vascular Surgery Volume 65, Issue 2, Pages 558-570.e10 (February 2017) DOI: 10.1016/j.jvs.2016.10.089 Copyright © 2016 Terms and Conditions

Fig 1 Preferred Reporting Items of Systematic Reviews and Meta-Analyses flow diagram. We identified 549 papers through searching the MEDLINE, Scopus, Embase, Web of Science, and Cochrane Library database. After duplicate papers were removed, 506 were screened, 492 were excluded based on their title or abstract, and 14 full-text articles were assessed for eligibility. One article was identified through searching reference lists of full-text articles assessed for eligibility. Ten articles were included in quantitative synthesis, and four articles were excluded. BIOLUX P-1, Paclitaxel-Releasing Balloon in Femoropopliteal Lesions Using a BTHC Excipient; DEB, drug-eluting balloon; DEBELLUM, Drug Eluting Balloon Evaluation for Lower Limb mUltilevel treatMent; FemPac, Inhibition of Restenosis in Femoropopliteal Arteries Paclitaxel-Coated Versus Uncoated Balloon: Femoral Paclitaxel Randomized Pilot Trial; LEVANT I, Lutonix Paclitaxel-Coated Balloon for the Prevention of Femoropopliteal Restenosis; LEVANT II, A Prospective, Multicenter, Registry of the Lutonix Drug Coated Balloon for Treatment of Femoropopliteal Arteries; PACIFIER, Paclitaxel-coated Balloons in Femoral Indication to Defeat Restenosis; IN PACT SFA I, Randomized Trial of IN.PACT Admiral Drug Eluting Balloon vs Standard PTA for the Treatment of SFA and Proximal Popliteal Arterial Disease. Journal of Vascular Surgery 2017 65, 558-570.e10DOI: (10.1016/j.jvs.2016.10.089) Copyright © 2016 Terms and Conditions

Fig 2 Meta-analysis comparing the outcomes of binary restenosis (BR) and late lumen loss (LLL) at 6 months between patients treated with drug-eluting balloons (DEBs) and percutaneous transluminal angioplasty (PTA). Forest plots demonstrate the odds ratios (ORs, black squares) and 95% confidence intervals (CI, gray lines) for the comparison of BR in patients treated with DEBs and PTA and the mean difference (M, black squares) with 95% CI (gray lines) for the comparison of LLL in patients treated with DEBs and PTA. The diamond represents the total OR or MD, respectively, calculated in this meta-analysis. Journal of Vascular Surgery 2017 65, 558-570.e10DOI: (10.1016/j.jvs.2016.10.089) Copyright © 2016 Terms and Conditions

Fig 3 Meta-analysis demonstrates the association of target lesion revascularization (TLR) in patients treated with drug-eluting balloons (DEBs) compared with percutaneous transluminal angioplasty (PTA) at 6, 12, and 24 months. The odds ratios (OR, black squares) with 95% confidence intervals (CI, gray lines) were calculated for each trial. The diamonds represent the total OR calculated in this meta-analysis. Journal of Vascular Surgery 2017 65, 558-570.e10DOI: (10.1016/j.jvs.2016.10.089) Copyright © 2016 Terms and Conditions

Supplementary Fig 1 (online only) Meta analysis comparing the outcomes of death and amputation at 6, 12, and 24 months between patients treated drug-eluting balloons (DEBs) and percutaneous transluminal angioplasty (PTA). Forest plot demonstrating odds ratios (OR) and 95% confidence intervals (CI; horizontal lines) for the comparison of death in patients treated with DEBs and PTA at 6, 12 and 24 months. The solid squares indicate the mean difference and are proportional to the weights used in the meta-analysis. The diamond represents the total OR calculated in this meta-analysis. Forest plot demonstrating mean difference (OR) with 95% CI (horizontal lines) for the comparison of amputation in patients treated with DEBs and PTA at 6, 12, and 24 months. The solid squares indicate the mean difference and are proportional to the weights used in the meta-analysis. The diamond represents the total OR calculated in this meta-analysis. M-H, Mantel-Haenszel. Journal of Vascular Surgery 2017 65, 558-570.e10DOI: (10.1016/j.jvs.2016.10.089) Copyright © 2016 Terms and Conditions

Supplementary Fig 2 (online only) Funnel plots assessing for risk of bias in data examining binary restenosis (BR) and late lumen loss (LLL) at 6 months and target lesion revascularization (TLR) at 6, 12, and 24 months. Journal of Vascular Surgery 2017 65, 558-570.e10DOI: (10.1016/j.jvs.2016.10.089) Copyright © 2016 Terms and Conditions